🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Chong Qin

Ministry of Education

ORCID: 0000-0001-8108-1698

Also affiliated with Target (United States), Ministry of Education of the People's Republic of China, Qingdao University of Science and Technology, Qingdao National Laboratory for Marine Science and Technology, Marine Biomedical Research Institute of Qingdao, Ocean University of China

ChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: “Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer”.

Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer

Journal of Medicinal Chemistry(2019)10.1021/acs.jmedchem.8b01631

N/A

0.883DataRank · unranked

360 citations

Chao Wang, Chong Qin, Weiguo Xiang, Ester Fernandez-Salas, Chao-Yie Yang +8 more

Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00900

N/A

0DataRank · unranked

142 citations

Lijie Zhao, Xin Han, Chong Qin, Bukeyan Miao, Donna McEachern +10 more

Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00882

N/A

0DataRank · unranked

139 citations

Lijie Zhao, Weiguo Xiang, Chong Qin, Bukeyan Miao, Donna McEachern +8 more

Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00405

N/A

0DataRank · unranked

58 citations

Lijie Zhao, Weiguo Xiang, Bukeyan Miao, Chong Qin, Mi Wang +16 more

Precise Conformational Control Yielding Highly Potent and Exceptionally Selective BRD4 Degraders with Strong Antitumor Activity

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00520

N/A

0DataRank · unranked

27 citations

Biao Hu, Fuming Xu, Mi Wang, Chong Qin, Donna McEachern +3 more